Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ)
CNY 8.45
(0.24%)
CNY 8.45
(0.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 962.8 Million | 1.46 Billion | 1.56 Billion | 1.17 Billion | 1.37 Billion | 1 Billion |
| Cost of Revenue | 733.52 Million | 980.78 Million | 1.2 Billion | 816.5 Million | 1.05 Billion | 655.37 Million |
| Gross Profit | 229.27 Million | 481.65 Million | 358.53 Million | 356.34 Million | 318.71 Million | 350.03 Million |
| Operating Expenses | 244.86 Million | 320.33 Million | 228.57 Million | 218.35 Million | 202.2 Million | 161.56 Million |
| Selling, General and Administrative Expenses | 124.53 Million | 213.7 Million | 105.83 Million | 128.28 Million | 103.8 Million | 76.87 Million |
| Research and Development Expenses | 41.5 Million | 40.44 Million | 53.04 Million | 46.66 Million | 54.41 Million | 23.98 Million |
| Other Expenses | 28.4 Million | 66.18 Million | 69.69 Million | 43.4 Million | 43.97 Million | -7014.47 |
| Cost and Expenses | 967.24 Million | 1.3 Billion | 1.43 Billion | 1.03 Billion | 1.25 Billion | 816.94 Million |
| Operating Income | 5.64 Million | 152.4 Million | 131.66 Million | 133.97 Million | 117.62 Million | 212.29 Million |
| Interest Expense | 627.26 Thousand | 664.41 Thousand | 2.44 Million | 1.2 Million | 287.61 Thousand | 7250.00 |
| Income Tax Expense | 34.46 Million | 20.34 Million | 10.8 Million | 11.91 Million | 9.44 Million | 33.15 Million |
| Earnings before Tax | 6.05 Million | 153.06 Million | 129.85 Million | 130.57 Million | 116.35 Million | 212.06 Million |
| Net Income | -12.31 Million | 140.34 Million | 111.41 Million | 105.55 Million | 89.93 Million | 178.58 Million |
| Earnings Per Share Basic | -0.04 | 0.48 | 0.38 | 0.37 | 0.31 | 0.62 |
| Earnings Per Share Diluted | -0.04 | 0.48 | 0.38 | 0.37 | 0.31 | 0.62 |
| Weighted Average Shares Outstanding | 294.55 Million | 294.31 Million | 294.68 Million | 288.48 Million | 288.34 Million | 289.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 294.68 Million | 294.68 Million | 294.68 Million | 288.51 Million | 288.34 Million | 289.9 Million |
| Gross Margin | 0.24 | 0.33 | 0.23 | 0.30 | 0.23 | 0.35 |
| EBIT Margin | 0.15 | 0.22 | 0.17 | 0.23 | 0.18 | 0.29 |
| Profit Margin | -0.01 | 0.10 | 0.07 | 0.09 | 0.07 | 0.18 |
| EBITDA | 141.6 Million | 293.38 Million | 240.75 Million | 242.59 Million | 226.07 Million | 291.86 Million |
| Earnings Before Tax Margin | 0.01 | 0.10 | 0.08 | 0.11 | 0.09 | 0.21 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 192.89 Million | 229.17 Million | 193.55 Million | 962.8 Million | 167.24 Million | 224.38 Million |
| Cost of Revenue | 158.54 Million | 173.06 Million | 140.27 Million | 733.52 Million | 166.44 Million | 165.67 Million |
| Gross Profit | 34.35 Million | 56.11 Million | 53.28 Million | 229.27 Million | 798.41 Thousand | 58.7 Million |
| Operating Expenses | 35.3 Million | 42.26 Million | 37.47 Million | 205 Million | 120.2 Million | 65.09 Million |
| Selling, General and Administrative Expenses | 53.37 Million | 4.75 Million | 27.45 Million | - | 24.19 Million | 111 Million |
| Research and Development Expenses | 8.83 Million | 11.52 Million | 10.01 Million | - | 4.99 Million | 13.2 Million |
| Other Expenses | -26.89 Million | 2909.60 | -313.72 Thousand | -1.16 Million | -91.01 Million | 3.64 Million |
| Cost and Expenses | 193.85 Million | 215.32 Million | 177.74 Million | 938.52 Million | 286.65 Million | 230.77 Million |
| Operating Income | 8.05 Million | 26.95 Million | 15.8 Million | 24.27 Million | -119.4 Million | 1.58 Million |
| Interest Expense | 182.25 Thousand | 112.62 Thousand | 108.34 Thousand | 374.4 Thousand | 119.28 Thousand | 104.06 Thousand |
| Income Tax Expense | 150.11 Thousand | 4.31 Million | 5.35 Million | 34.46 Million | 4.3 Million | 21.16 Million |
| Earnings before Tax | 7.83 Million | 26.95 Million | 32.73 Million | 3.39 Million | -66.35 Million | 5.23 Million |
| Net Income | 9.37 Million | 23.8 Million | 28.68 Million | -12.31 Million | -58.74 Million | -9.69 Million |
| Earnings Per Share Basic | 0.03 | 0.08 | 0.10 | - | -0.20 | -0.03 |
| Earnings Per Share Diluted | 0.03 | 0.08 | 0.10 | - | -0.20 | -0.03 |
| Weighted Average Shares Outstanding | 292.82 Million | 292.82 Million | 294.68 Million | 294.68 Million | 294.68 Million | 294.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 292.82 Million | 292.82 Million | 294.68 Million | 294.68 Million | 294.68 Million | 294.68 Million |
| Gross Margin | 0.18 | 0.24 | 0.28 | 0.24 | 0.00 | 0.26 |
| EBIT Margin | 0.04 | 0.12 | 0.16 | - | -0.51 | 0.03 |
| Profit Margin | 0.05 | 0.10 | 0.15 | -0.01 | -0.35 | -0.04 |
| EBITDA | 8.01 Million | 27.22 Million | 31.9 Million | - | -85.6 Million | 6.19 Million |
| Earnings Before Tax Margin | 0.04 | 0.12 | 0.08 | 0.03 | -0.71 | 0.01 |
000831
002992
000425
WFC
PRFO
LOMA